Categories: National Politics

Top NSCN-IM leader hospitalised

Kohima, July 24 (SocialNews.XYZ) Senior Naga leader and NSCN-IM General Secretary Th Muivah was admitted to a private hospital in Dimapur in Nagaland, official sources said late on Saturday night.

Nagaland health officials neither denied nor confirmed the media report that the top leader of the Isak-Muivah faction of the National Socialist Council of Nagalim (NSCN-IM) have tested Covid-19 positive two days back.

A security official said that Muivah was admitted to the Referral Hospital in Dimapur late on Saturday evening and his condition is normal with the oxygen level being 93/94.

The 87-year-old NSCN (IM) leader along with the other leaders of the outfit came to Dimapur to attend the important meeting of the core committee on the long awaited Naga political issue.

A large contingent of security personnel were on guard outside the private hospital in Dimapur, the second most important city and commercial hub of Nagaland after the state capital Kohima.

The NSCN-IM, the dominant Naga group, since August 1997, held around 80 rounds of negotiations with the Centre and Muivah has been leading the delegation of the outfit.The Central government has been separately holding the peace talks with the NSCN-IM and eight other outfits which came together a few years ago under the banner of "Naga National Political Groups" (NNPGs).

The Naga outfits also entered into a ceasefire agreement with the government of India.

Source: IANS

Facebook Comments

About Gopi

Gopi Adusumilli is a Programmer. He is the editor of SocialNews.XYZ and President of AGK Fire Inc.

He enjoys designing websites, developing mobile applications and publishing news articles on current events from various authenticated news sources.

When it comes to writing he likes to write about current world politics and Indian Movies. His future plans include developing SocialNews.XYZ into a News website that has no bias or judgment towards any.

He can be reached at gopi@socialnews.xyz

Share
More

This website uses cookies.